207 related articles for article (PubMed ID: 15482105)
1. The next generation of HIV/AIDS drugs: novel and developmental antiHIV drugs and targets.
Turpin JA
Expert Rev Anti Infect Ther; 2003 Jun; 1(1):97-128. PubMed ID: 15482105
[TBL] [Abstract][Full Text] [Related]
2. New anti-HIV agents and targets.
De Clercq E
Med Res Rev; 2002 Nov; 22(6):531-65. PubMed ID: 12369088
[TBL] [Abstract][Full Text] [Related]
3. Highly active antiretroviral therapy: current state of the art, new agents and their pharmacological interactions useful for improving therapeutic outcome.
Barbaro G; Scozzafava A; Mastrolorenzo A; Supuran CT
Curr Pharm Des; 2005; 11(14):1805-43. PubMed ID: 15892677
[TBL] [Abstract][Full Text] [Related]
4. New developments in anti-HIV chemotherapy.
De Clercq E
Biochim Biophys Acta; 2002 Jul; 1587(2-3):258-75. PubMed ID: 12084468
[TBL] [Abstract][Full Text] [Related]
5. HIV-1 gag: an emerging target for antiretroviral therapy.
Tedbury PR; Freed EO
Curr Top Microbiol Immunol; 2015; 389():171-201. PubMed ID: 25731773
[TBL] [Abstract][Full Text] [Related]
6. The development of anti-HIV-1 drugs.
Lu XF; Chen ZW
Yao Xue Xue Bao; 2010 Feb; 45(2):165-76. PubMed ID: 21348415
[TBL] [Abstract][Full Text] [Related]
7. New developments in anti-HIV chemotherapy.
De Clercq E
Curr Med Chem; 2001 Nov; 8(13):1543-72. PubMed ID: 11562282
[TBL] [Abstract][Full Text] [Related]
8. Preclinical evaluation of a zinc finger inhibitor targeting lentivirus nucleocapsid protein in SIV-infected monkeys.
Schito ML; Soloff AC; Slovitz D; Trichel A; Inman JK; Appella E; Turpin JA; Barratt-Boyes SM
Curr HIV Res; 2006 Jul; 4(3):379-86. PubMed ID: 16842089
[TBL] [Abstract][Full Text] [Related]
9. Peptide inhibition of HIV-1: current status and future potential.
Kaushik-Basu N; Basu A; Harris D
BioDrugs; 2008; 22(3):161-75. PubMed ID: 18481899
[TBL] [Abstract][Full Text] [Related]
10. Recent Advances in HIV-1 Gag Inhibitor Design and Development.
Dick A; Cocklin S
Molecules; 2020 Apr; 25(7):. PubMed ID: 32272714
[TBL] [Abstract][Full Text] [Related]
11. HIV-1 integrase: a target for new AIDS chemotherapeutics.
Anthony NJ
Curr Top Med Chem; 2004; 4(9):979-90. PubMed ID: 15134552
[TBL] [Abstract][Full Text] [Related]
12. A mimic of HIV-1 nucleocapsid protein impairs reverse transcription and displays antiviral activity.
Druillennec S; Dong CZ; Escaich S; Gresh N; Bousseau A; Roques BP; Fournié-Zaluski MC
Proc Natl Acad Sci U S A; 1999 Apr; 96(9):4886-91. PubMed ID: 10220388
[TBL] [Abstract][Full Text] [Related]
13. Inhibitors of HIV-1 reverse transcriptase and integrase: classical and emerging therapeutical approaches.
Tarrago-Litvak L; Andreola ML; Fournier M; Nevinsky GA; Parissi V; de Soultrait VR; Litvak S
Curr Pharm Des; 2002; 8(8):595-614. PubMed ID: 11945161
[TBL] [Abstract][Full Text] [Related]
14. [Advances in novel anti-HIV-1 drugs and drug candidates: 2005-2008].
Zheng PR; Xue H; Xiao ZY; Liu G
Yao Xue Xue Bao; 2010 Feb; 45(2):154-64. PubMed ID: 21351426
[TBL] [Abstract][Full Text] [Related]
15. Synthesis and biological properties of amino acid amide ligand-based pyridinioalkanoyl thioesters as anti-HIV agents.
Song Y; Goel A; Basrur V; Roberts PE; Mikovits JA; Inman JK; Turpin JA; Rice WG; Appella E
Bioorg Med Chem; 2002 May; 10(5):1263-73. PubMed ID: 11886789
[TBL] [Abstract][Full Text] [Related]
16. Combinatorial chemistry as a tool for targeting different stages of the replicative HIV-1 cycle.
Mugnaini C; Petricci E; Corelli F; Botta M
Comb Chem High Throughput Screen; 2005 Aug; 8(5):387-401. PubMed ID: 16101579
[TBL] [Abstract][Full Text] [Related]
17. Synthesis and biological properties of novel pyridinioalkanoyl thiolesters (PATE) as anti-HIV-1 agents that target the viral nucleocapsid protein zinc fingers.
Turpin JA; Song Y; Inman JK; Huang M; Wallqvist A; Maynard A; Covell DG; Rice WG; Appella E
J Med Chem; 1999 Jan; 42(1):67-86. PubMed ID: 9888834
[TBL] [Abstract][Full Text] [Related]
18. [The HIV replication cycle. Established therapeutic targets and potential targets].
Alcamà J
Enferm Infecc Microbiol Clin; 2008 Nov; 26 Suppl 12():3-10. PubMed ID: 19572419
[TBL] [Abstract][Full Text] [Related]
19. HIV-1 inactivation by nucleic acid aptamers.
Held DM; Kissel JD; Patterson JT; Nickens DG; Burke DH
Front Biosci; 2006 Jan; 11():89-112. PubMed ID: 16146716
[TBL] [Abstract][Full Text] [Related]
20. The integrase of the human immunodeficiency virus as a novel target for the antiviral therapy of AIDS.
Witvrouw M; Debyser Z
Verh K Acad Geneeskd Belg; 2003; 65(5):325-34. PubMed ID: 14671848
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
